| Date | Subject |
| 10/24/2008 10:06:17 AM | |
| Oral Fumarate Reduces Disease Activity in Relapsing-Remitting MS |
| 10/10/2008 05:38:03 PM | |
| FDA Approves C1 Inhibitor Protein for the Prevention of Hereditary Angioedema Attacks |
| 10/07/2008 04:40:13 PM | |
| Circumcision Not Associated With Reduced Risk of HIV for Men Who Have Sex With Men |
| 10/06/2008 04:10:38 PM | |
| Flu Vaccine Not Associated With Reduced Hospitalisations or Outpatient Visits Among Young Children |
| 10/02/2008 12:40:06 PM | |
| Maraviroc Shows Efficacy Over 48 Weeks in Drug-Resistant Patients With R5 HIV |
| 10/02/2008 12:25:52 PM | |
| FDA Approves Atazanavir Boosted With Ritonavir for Treatment-Naïve HIV Patients |
| 09/30/2008 04:57:01 PM | |
| Changing Dosing, Administration of Anthrax Vaccine Reduces Side Effects |
| 09/29/2008 04:44:45 PM | |
| TREM-2 Is More Abundant in Spinal Fluid of Patients With MS |
| 09/25/2008 04:06:22 PM | |
| Majority of Children Vaccinated Against Hepatitis B Not at Increased Risk of MS |
| 09/25/2008 09:56:55 AM | |
| Glatiramer Acetate Reduces Relapses With Lower Cost in Patients With Multiple Sclerosis: Presented at ANA |
| 09/24/2008 04:31:36 PM | |
| Disease Modifying Drugs Tie for Efficacy in Multiple Sclerosis: Presented at ANA |
| 09/24/2008 04:19:19 PM | |
| Acute Multiple-Sclerosis Relapses Rarely Result in Permanent Disability: Presented at ANA |
| 09/24/2008 02:36:30 PM | |
| Alemtuzumab Is Better Than Interferon Beta-1a in Achieving Clinically Disease-Free State in Patients With Relapsing-Remitting Multiple Sclerosis: Presented at WCTRMS |
| 09/24/2008 02:24:06 PM | |
| Magnetic Resonance Imaging Can Predict Who Will Develop Multiple Sclerosis: Presented at WCTRMS |
| 09/24/2008 01:12:31 PM | |
| Natalizumab May Modulate Clinical Disease Activity in Patients With Multiple Sclerosis: Presented at WCTRMS |
| 09/22/2008 01:18:16 PM | |
| Sustained-Release Fampridine Improves Walking and Leg Strength in Patients With Multiple Sclerosis: Presented at WCTRMS |
| 09/22/2008 01:16:20 PM | |
| Greater Tolerability Achieved With New Formulation Subcutaneous Interferon-Beta-1a for Relapsing-Remitting Multiple Sclerosis: Presented at WCTRMS |
| 09/22/2008 10:10:04 AM | |
| Glatiramer Acetate Offers Long-Term Disease Stability for Patients With Multiple Sclerosis: Presented at WCTRMS |
| 09/17/2008 03:37:33 PM | |
| Flu Shot During Pregnancy Protects Newborn |
| 09/17/2008 01:11:24 PM | |
| HIV-Infected Patients With Long-Term Viral Suppression Have Slower CD4 Recovery With Tenofovir Regimens: Presented at ACCP |
| 09/15/2008 01:03:50 PM | |
| FDA Approves Expanded Uses for HPV Vaccine to Include Prevention of Certain Vulvar, Vaginal Cancers |
| 09/12/2008 05:28:23 PM | |
| FDA Approves Treatment for Chronic Inflammatory Demyelinating Polyneuropathy |
| 09/04/2008 04:51:11 PM | |
| Study Shows No Connection Between MMR Vaccine and Autism, GI Disturbances |
| 09/03/2008 01:21:05 PM | |
| Vaccinating Parents Protects Newborns in the NICU Against Pertussis |
| 09/02/2008 04:43:19 PM | |
| Most Vaccine-Allergic Children Still Can Be Safely Vaccinated |
| 09/02/2008 02:17:53 PM | |
| Higher Anaphylaxis Rates After HPV Vaccination in Australia |
| 08/29/2008 01:10:42 PM | |
| Etravirine Approved in the European Union for HIV Combination Therapy |
| 08/29/2008 12:44:33 PM | |
| Flu Shot Does Not Reduce Risk of All-Cause Mortality in Elders |
| 08/28/2008 03:45:49 PM | |
| Fracture Prevalence Is Significantly Higher in HIV-Infected Patients |
| 08/26/2008 01:28:38 PM | |
| Vaccine for the Prevention of Shingles Approved in Canada |
| 08/26/2008 01:08:24 PM | |
| Alutard SQ Approved for Asthma Prevention in Germany |
| 08/22/2008 12:57:22 PM | |
| FDA Approves Romiplostim to Treat Chronic Immune Thrombocytopenic Purpura |
| 08/21/2008 03:43:12 PM | |
| Measles Cases on Rise in US, Refusal to Vaccinate Cited |
| 08/21/2008 03:24:19 PM | |
| Health, Economic Outcomes of HPV Vaccine in Adolescent Girls Analysed |
| 08/15/2008 01:46:44 PM | |
| Metronomic Dosing of IL-2 Shows Promise in Prostate Cancer Patients |
| 08/08/2008 04:51:34 PM | |
| Atazanavir-Based Regimen Has Greater Risk of Treatment Failure Compared to Efavirenz-Based Combination: Presented at AIDS 2008 |
| 08/08/2008 04:49:33 PM | |
| Pharmacokinetic Interaction Between Anti-TB Agent Rifabutin and HIV Drug Rilpivirine: Presented at AIDS 2008 |
| 08/08/2008 04:45:32 PM | |
| Pregabalin No Better Than Placebo in Treating HIV-Associated Neuropathic Pain: Presented at AIDS 2008 |
| 08/08/2008 04:43:26 PM | |
| Antiretroviral Treatment Lowers Cardiovascular Risk in HIV+ Patients |
| 08/08/2008 04:41:23 PM | |
| Fixed-Dose Combination Tablets Simplify Antiretroviral Treatment for Children in India With HIV: Presented at AIDS 2008 |
| 08/08/2008 04:39:25 PM | |
| Fosamprenavir Offers Results Similar to Those of Other Protease Inhibitors When Patients With HIV Switch Regimens: Presented at AIDS 2008 |
| 08/08/2008 04:36:22 PM | |
| Incarcerated HIV Patients Have Similar Responses to Antiretrovirals as Other Populations: Presented at AIDS 2008 |
| 08/07/2008 04:26:29 PM | |
| Maraviroc Treatment Improves CD-Positive Cell Rebound in Patients With HIV: Presented at AIDS 2008 |
| 08/07/2008 04:21:30 PM | |
| Etravirine Suppresses HIV Viral Load With or Without Raltegravir or Darunavir Combination: Presented at AIDS 2008 |
| 08/07/2008 04:19:32 PM | |
| HIV Patients With Injection-Site Reactions Switched From Enfuvirtide to Raltegravir: Presented at AIDS 2008 |
| 08/07/2008 12:30:18 PM | |
| Switching From Stavudine to Efavirenz Maintains Long-Term Control of HIV, Improves Metabolic Profile: Presented at AIDS 2008 |
| 08/07/2008 12:28:32 PM | |
| Heterosexual HIV Infectivity Rate May Be Underestimated |
| 08/07/2008 12:23:45 PM | |
| Experimental Apricitabine Demonstrates Promising Safety at 24 Weeks: Presented at AIDS 2008 |
| 08/06/2008 05:12:52 PM | |
| Raltegravir Maintains Efficacy, Tolerability at 96 Weeks: Presented at AIDS 2008 |
| 08/06/2008 04:36:20 PM | |
| Investigative Rilpivirine Maintains Efficacy Against Efavirenz at 96 Weeks: Presented at AIDS 2008 |
| 08/05/2008 04:54:56 PM | |
| FDA Approves 6 Flu Vaccines for 2008-2009 Influenza Season |
| 08/05/2008 04:32:26 PM | |
| Antiretroviral Treatment During Pregnancy Effective in Preventing HIV Transmission From Mothers to Newborns: Presented at AIDS 2008 |
| 08/05/2008 04:27:41 PM | |
| Long-Term HIV Treatment May Reduce Risk for Atherosclerosis |
| 08/05/2008 04:14:14 PM | |
| Experimental Tesamorelin Reduces Abdominal Body Fat in Patients With HIV, Does Not Affect Glucose Tolerance: Presented at AIDS 2008 |
| 08/05/2008 04:12:20 PM | |
| Antiretroviral Therapy for Pregnant Women Causes Little Harm to Newborns: Presented at AIDS 2008 |
| 08/04/2008 05:28:33 PM | |
| Antiretroviral Therapy Has Increased HIV Life Expectancy by 13 Years |
| 08/04/2008 02:22:49 PM | |
| Antiretrovirals Offer Similar Survival Rates for Injecting Drug Users and Non-Users With HIV: Presented at AIDS 2008 |
| 08/04/2008 02:18:12 PM | |
| Guidelines Suggest Earlier Treatment for HIV-Infected Patients: Presented at AIDS 2008 |
| 08/04/2008 02:16:28 PM | |
| New Estimates Raise HIV Incidence Rates in the United States |
| 08/04/2008 01:13:59 PM | |
| Growth Hormone Reduces Abdominal Fat, but Increases Risk of Glucose Intolerance in Patients With HIV: Presented at AIDS 2008 |
| 08/04/2008 01:09:28 PM | |
| Efavirenz Superior to Nevirapine for Treating HIV in Coinfected Patients Treated With Rifampin for Tuberculosis: Presented at AIDS 2008 |
| 08/04/2008 10:18:43 AM | |
| HAART May Benefit HIV-Infected Injection Drug Users |
| 08/04/2008 10:16:19 AM | |
| Growth Hormone for HIV-Related Abdominal Fat Not Effective for All Metabolic Measures |
| 08/04/2008 10:14:05 AM | |
| International AIDS Society Updates US Guidelines for HIV Treatment |
| 08/01/2008 06:30:31 PM | |
| Atazanavir/Ritonavir as Effective as Lopinavir/Ritonavir in HIV Treatment-Naive Patients |
| 08/01/2008 03:16:48 PM | |
| Routine HIV Testing Recommended for All Women, Regardless of Individual Risk Factors |
| 08/01/2008 03:04:09 PM | |
| Immunotherapy Benefits Children With High-Risk Sarcomas |
| 07/31/2008 06:30:51 PM | |
| Efficacy of Flu Shots in Elderly Overestimated |
| 07/28/2008 12:43:39 PM | |
| Additional, Early Vaccination May Reduce Measles Outbreaks in Developing Countries |
| 07/24/2008 02:50:15 PM | |
| FDA Recommends Genetic Screening Prior to Treatment With Abacavir |
| 07/18/2008 02:35:20 PM | |
| HIV Conquers Immune System Faster Than Previously Realised |
| 07/17/2008 06:30:48 PM | |
| AB42 Immunisation Clears Brain Plaques, Does Not Prevent Dementia in Alzheimer's |
| 07/17/2008 02:36:22 PM | |
| Booster Shot May Help Control Future Avian Influenza Pandemic |
| 07/16/2008 10:13:35 AM | |
| Nationwide Voluntary Recall of 2 Lots of Sodium Polystyrene Sulfonate Suspension in the United States and Puerto Rico |
| 07/09/2008 02:55:00 PM | |
| Pneumococcal Vaccine Proves Very Effective After Only 2 Years in Norway |
| 07/03/2008 06:30:17 PM | |
| Vitespen Shows No Increased Survival in Postoperative Renal Cell Carcinoma Patients |
| 07/03/2008 02:55:41 PM | |
| Infant Formula Blocks HIV Transmission via Breastfeeding |
| 07/02/2008 04:13:10 PM | |
| HAART May Increase Asthma Risk in Children With HIV |
| 07/02/2008 12:00:01 PM | |
| Multitarget Immune Therapy Improves Outcomes of Severe Lupus Nephritis |
| 06/25/2008 04:42:14 PM | |
| Potential Risk of Cardiac Events in Patients Treated With Abacavir-Containing Products |
| 06/25/2008 10:20:55 AM | |
| FDA Approves New Combination Vaccine for Children |
| 06/24/2008 05:12:21 PM | |
| FDA Approves New Tipranavir Oral Solution for Treatment-Experienced Paediatric, Adolescent HIV Patients |
| 06/23/2008 02:21:09 PM | |
| FDA Approves Pentacel, a Paediatric Combination Vaccine |
| 06/17/2008 05:23:10 PM | |
| TGA Approves Panvax, Avian Flu Vaccine |
| 06/16/2008 11:50:54 AM | |
| Duloxetine Safety in Fibromyalgia Sustained Up to 60 Weeks and Comparable to Other Uses of the Drug: Presented at EULAR |
| 06/16/2008 11:47:03 AM | |
| Belimumab Effective in Patients With Serologically Active Systemic Lupus Erythematosus: Presented at EULAR |
| 06/11/2008 10:22:19 PM | |
| Autologous Haematopoietic Stem Cell Transplantation After Immunosuppressive Therapy Effective and Safe in Multiple Sclerosis: Presented at ENS |
| 06/11/2008 10:17:51 PM | |
| C1 Esterase Inhibitor Concentrate Effective in Treating Patients With Acute Abdominal and Facial Hereditary Angio-Oedema: Presented at EAACI |
| 06/11/2008 10:29:49 AM | |
| Sublingual Tablets Provide Effective and Safe Immunotherapy for Grass Pollen Allergy: Presented at EAACI |
| 06/11/2008 10:22:02 AM | |
| Sublingual Immunotherapy With Aqueous Vaccine Controls Allergic Diseases: Presented at EAACI |
| 06/10/2008 04:27:45 PM | |
| Short Course Immunotherapy Containing Monophosphoryl Lipid A Adjuvant Shows Good Long-Term Efficacy: Presented at EAACI |
| 06/10/2008 03:56:23 PM | |
| Adherence to Disease-Modifying Therapy in Multiple Sclerosis Highest in Subcutaneous Interferon Beta-1a and Glatiramer Acetate: Presented at ENS |
| 06/09/2008 04:56:53 PM | |
| High-Dose Cyclophosphamide Appears to Reduce Disease Activity, Disability in Patients With MS |
| 06/06/2008 10:29:47 AM | |
| Extended Infant Antiretroviral Prophylaxis Reduces HIV Risk During Breastfeeding |
| 06/03/2008 03:40:30 PM | |
| Anti-CD20 Therapy Effective Against B-Cell Depletion in Rheumatoid Arthritis |
| 05/26/2008 08:32:15 AM | |
| Immune-Modulating Therapies May Carry Risks of Serious Non-TB Infections |
| 05/23/2008 04:44:18 PM | |
| Novel Influenza Vaccine Induces Immunity Throughout Flu Season: Presented at ESPID |
| 05/23/2008 03:37:12 PM | |
| Inactivated Influenza Vaccine Reduces Recurrence of Acute Otitis Media: Presented at ESPID |
| 05/23/2008 03:29:45 PM | |
| Cervical-Cancer Vaccine Demonstrates Long-Term Safety in Large Cohort: Presented at ESPID |
| 05/22/2008 05:14:04 PM | |
| Rotavirus Vaccine Can Be Safely Co-Administered With Standard Childhood Vaccines: Presented at ESPID |
| 05/20/2008 02:53:52 PM | |
